In Vivo

In vivo (Latin for 'within the living') describes scientific experimentation conducted within whole, living organisms, ranging from non-human animal models (rodents, canines, non-human primates) to human clinical trial participants. In vivo experiments preserve intact physiological feedback loops, organ systems, blood circulation, and renal/hepatic clearance.

A substance that demonstrates potent effects in vitro frequently fails in vivo due to rapid proteolytic degradation, poor tissue penetration, or acute toxicities.

“In vivo” covers both a laboratory rat and a human trial participant, and marketing often blurs the difference. A tendon study in rodents and a phase 3 trial in thousands of people are both in vivo, yet they carry very different weight. When a peptide is described as having in vivo evidence, it is worth asking which species, how many subjects and what outcome was measured.

Animal results translate to people only part of the time. A 2024 umbrella review of animal-to-human translation found that about 50% of therapies tested in animals progressed to any human study, 40% to a randomised controlled trial and only 5% to regulatory approval. Positive animal and human results agreed in 86% of comparisons, so animal studies are informative, but they rarely settle whether a treatment works.

Species differences matter especially for peptides, whose behaviour depends on enzymes, receptors and blood proteins that vary between animals. Semaglutide had a plasma half-life of about 46 hours after intravenous administration in mini-pigs, compared with roughly one week in humans. Effects and safety margins seen in one species cannot simply be carried over to another.

“In vivo means it was tested in people”

In vivo only means the experiment took place in a living organism. Most in vivo peptide research, including most work on BPC-157 and TB-500, has been in rodents and other animals. Human evidence comes from clinical studies, which should be named as such. Check the methods section before assuming a study involved people.

“If it heals rats, it will heal people”

Rodent models differ from humans in metabolism, healing biology and how injuries are created and measured. Across biomedical fields, only about 5% of therapies tested in animals have gone on to regulatory approval for human use, according to a 2024 umbrella review. Animal success is a reason to run human trials, not a substitute for them.

What does in vivo mean?

In vivo is Latin for “within the living”. It describes research carried out in a whole, living organism, such as a mouse, rat, pig, primate or human volunteer. Because organs, circulation, metabolism and the immune system are all working, in vivo studies show effects that experiments on isolated cells cannot.

Is in vivo research better than in vitro research?

Neither is better in general; they answer different questions. In vitro studies are precise and controlled and are good for mechanisms. In vivo studies are closer to real-world biology and capture absorption, metabolism and side effects. For deciding whether a treatment helps people, well-designed human trials outrank both animal and cell studies.

Has BPC-157 been tested in humans?

Very little. A 2025 systematic review of BPC-157 in orthopaedic sports medicine found 35 preclinical studies and one clinical study, a retrospective report of 12 patients with chronic knee pain, and no clinical safety data. Most of its in vivo evidence comes from animal models, and it is not FDA-approved for any use.

Why are animal studies required before human trials?

Before testing a drug in people, researchers must look for potential serious harm. FDA describes in vitro and in vivo studies as the two types of preclinical research, conducted under good laboratory practice rules. Animal studies help identify toxic effects and inform whether, and how cautiously, a compound should move into human trials.